This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Master Pharm Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Wichtige Informationen

n/a

Wachstumsrate der Gewinne

n/a

EPS-Wachstumsrate

Personal Products Gewinnwachstum7.8%
Wachstumsrate der Einnahmenn/a
Zukünftige Eigenkapitalrenditen/a
Analystenabdeckung

None

Zuletzt aktualisiertn/a

Jüngste Aktualisierungen zum künftigen Wachstum

Keine Aktualisierungen

Recent updates

Calculating The Intrinsic Value Of Master Pharm SA (WSE:MPH)

Feb 05
Calculating The Intrinsic Value Of Master Pharm SA (WSE:MPH)

Returns On Capital At Master Pharm (WSE:MPH) Have Hit The Brakes

Dec 13
Returns On Capital At Master Pharm (WSE:MPH) Have Hit The Brakes

A Look At The Intrinsic Value Of Master Pharm SA (WSE:MPH)

May 25
A Look At The Intrinsic Value Of Master Pharm SA (WSE:MPH)

Master Pharm (WSE:MPH) Will Will Want To Turn Around Its Return Trends

Mar 30
Master Pharm (WSE:MPH) Will Will Want To Turn Around Its Return Trends

Is Master Pharm SA's (WSE:MPH) Latest Stock Performance Being Led By Its Strong Fundamentals?

Mar 02
Is Master Pharm SA's (WSE:MPH) Latest Stock Performance Being Led By Its Strong Fundamentals?

I Ran A Stock Scan For Earnings Growth And Master Pharm (WSE:MPH) Passed With Ease

Feb 04
I Ran A Stock Scan For Earnings Growth And Master Pharm (WSE:MPH) Passed With Ease

Master Pharm (WSE:MPH) Is Growing Earnings But Are They A Good Guide?

Jan 08
Master Pharm (WSE:MPH) Is Growing Earnings But Are They A Good Guide?

Here's What To Make Of Master Pharm's (WSE:MPH) Returns On Capital

Dec 18
Here's What To Make Of Master Pharm's (WSE:MPH) Returns On Capital

Master Pharm SA (WSE:MPH) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

Nov 27
Master Pharm SA (WSE:MPH) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?

In diesem Abschnitt stellen wir normalerweise Umsatz- und Gewinnwachstumsprognosen vor, die auf den Konsensschätzungen professioneller Analysten basieren, um den Anlegern zu helfen, die Fähigkeit des Unternehmens zur Gewinnerzielung zu verstehen. Da Master Pharm jedoch nicht genügend Daten aus der Vergangenheit zur Verfügung gestellt hat und keine Analystenprognose vorliegt, können die zukünftigen Erträge nicht zuverlässig durch Extrapolation von Vergangenheitsdaten oder anhand von Analystenprognosen berechnet werden.

Dies ist eine recht seltene Situation, da 97 % der von SimplyWall St erfassten Unternehmen über Finanzdaten aus der Vergangenheit verfügen.

Gewinn- und Umsatzwachstumsprognosen

WSE:MPH - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (PLN Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
6/30/20227921517N/A
3/31/20227341717N/A
12/31/20217741013N/A
9/30/202172-31014N/A
6/30/202175246N/A
3/31/202169168N/A
12/31/20206101315N/A
9/30/202063121517N/A
6/30/202068131516N/A
3/31/202071121213N/A
12/31/2019711367N/A
9/30/2019739910N/A
6/30/201974989N/A
3/31/2019729910N/A
12/31/201875111314N/A
9/30/2018751135N/A
6/30/2018701046N/A
3/31/201868914N/A
12/31/2017648-6-3N/A
9/30/2017577-41N/A
6/30/2017526-42N/A
3/31/2017518-16N/A
12/31/2016497-15N/A
9/30/201650835N/A
6/30/201653745N/A
3/31/2016539N/A1N/A
12/31/2015498N/A3N/A
9/30/2015438N/A4N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: Insufficient data to determine if MPH's forecast earnings growth is above the savings rate (2.6%).

Ertrag vs. Markt: Insufficient data to determine if MPH's earnings are forecast to grow faster than the Polish market

Hohe Wachstumserträge: Insufficient data to determine if MPH's earnings are expected to grow significantly over the next 3 years.

Einnahmen vs. Markt: Insufficient data to determine if MPH's revenue is forecast to grow faster than the Polish market.

Hohe Wachstumseinnahmen: Insufficient data to determine if MPH's revenue is forecast to grow faster than 20% per year.


Wachstumsprognosen für den Gewinn je Aktie


Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Insufficient data to determine if MPH's Return on Equity is forecast to be high in 3 years time


Wachstumsunternehmen entdecken